Insulin-like growth factors in human breast cancer

Breast Cancer Research and Treatment

Volumn 52, Issue 1-3, 1998, Pages 175-184

  Ellis, Matthew J ^a   Jenkins, Sara ^a   Hanfelt, John ^a   Redington, Maura E ^a   Taylor, Marian ^b   Leek, Russel ^b   Siddle, Ken ^c   Harris, Adrian ^b  

^a GEORGETOWN UNIVERSITY   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Breast cancer; Chemotherapy; Hormone therapy; IGF binding proteins; IGF receptors; Insulin like growth factors (IGFs); Prognosis; Radiation therapy

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; MANNOSE 6 PHOSPHATE; PEPTIDE HORMONE; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; SOMATOMEDIN RECEPTOR; TYROSINE KINASE RECEPTOR;

APOPTOSIS; BREAST CANCER; BREAST DEVELOPMENT; BREAST EPITHELIUM; CANCER CHEMOTHERAPY; CELL SURVIVAL; EMBRYO DEVELOPMENT; FEMALE; GENE MUTATION; HORMONAL THERAPY; HUMAN; MITOGENESIS; POSTNATAL GROWTH; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; STROMA CELL;

EID: 0032444465     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006127621512     Document Type: Review

References (62)

1. Ellis M, Garmroudi F, Cullen K: Insulin receptors (IGF1 and IGF2). In: Bertino J (ed) Encyclopedia of Cancer, Vol 2. Academic Press, San Diego, 1997, pp 927-939
2. Siddle K, Soos M, Field C, et al: Hybrid and atypical insulin/insulin-like growth factor I receptors. Horm Res 41(Suppl 2):56-64, 1994
3. Morrione A, Valentinis B, Xu S-Q, et al: Insulin-like growth factor II stimulates cell proliferation through the insulin receptor. Proc Natl Acad Sci USA 94:3777-3782, 1997
4. Clemmons RD: Insulin-like growth factor binding proteins and their role in controlling IGF actions. Cytokine and Growth Factor Rev 8:45-62, 1997
5. Oh Y: IGF-independent regulation of breast cancer growth by IGF binding proteins. Breast Cancer Res Treat 47:283-293, 1998
6. Ellis MJC, Leav BA, Yang Z, et al: Affinity for the insulin-like growth factor-II (IGF-II) receptor inhibits autocrine IGF-II activity in MCF-7 breast cancer cells. Mol Endocrinol 10:286-297, 1996
7. Formisano P, Najjar S, Gross C, et al: Receptor-mediated internalization of insulin. Potential role of pp120/HA4, a substrate of the insulin receptor kinase. J Biol Chem 270:24073-24077, 1995
8. Yee D: The insulin-like growth factors and breast cancer - revisited. Breast Cancer Res Treat 47:197-199, 1998
9. Stewart A, Johnson M, May F, et al: Role of insulin-like growth factors and type I insulin-like growth factor receptor in the estrogen stimulated proliferation of human breast cancer cells. J Biol Chem 265:31172-21178, 1990
10. Kleinberg D: Role of IGF-I in normal mammary development. Breast Cancer Res Treat 47:201-208, 1998
11. Ruan W, Newman C, Kleinberg D: Intact and amino-terminally shortened forms of insulin-like growth factor I induce mammary gland differentiation and development. Proc Natl Acad Sci USA 89:10872-10876, 1992
12. Ruan W, Catanese V, Wieczorek R, et al: Estradiol enhances the stimulatory effect of insulin-like growth factor-1 (IGF1) on mammary development and growth hormone-induced IGF1 messenger ribonucleic acid. Endocrinol 136:1296-1302, 1995
13. el-Tanani M, Green C: Insulin/IGF-1 modulation of the expression of two estrogen-induced genes in MCF-7 cells. Mol Cell Endocrinol 121:29-35, 1996
14. Lee A, Weng C, Jackson J, et al: Activation of estrogen receptor-mediated gene transcription by IGF1 in human breast cancer cells. J Endocrinol 152:39-47, 1997
15. Hafner F, Holler E, von Angerer E: Effect of growth factors of estrogen mediated gene expression. J Steroid Biochem Molec Biol 58:385-393, 1996
16. Kato S, Endoh H, Masuhiro Y, et al: Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270:1491-1494, 1995
17. Sweeney KJ, Musgrove EA, Watts CK, et al: Cyclins and breast cancer [review]. Cancer Treat Res 83:141-70, 1996
18. Zwijsen R, Wientjens E, Klompmaker R, et al: CDK-independent activation of estrogen receptor by cyclin D1. Cell 88:405-415, 1997
19. Furlanetto R, Harwell S, Frick K: Insulin-like growth factor-I induces cyclin-D1 expression in MG63 human osteosarcoma cells in vitro. Mol Endocrinol 8:510-517, 1994
20. Guvakova M, Surmacz E: Overexpressed IGF-I receptors reduce estrogen growth requirements, enhance survival, and promote E-cadherin-mediated cell-cell adhesion in human breast cancer cells. Exp Cell Res 231:149-162, 1997
21. de Cupis A, Noonan D, Pirani P, et al: Comparison between novel steroid-like and conventional non-steroidal antioestrogens in inhibiting oestradiol- and IGF-I-induced proliferation of human breast cancer-derived cells. Br J Pharmacol 116:2391-2400, 1995
22. Harrington EA, Bennett MR, Fanidi A, et al: c-myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J 13:3286-3295, 1994
23. Christofori G, Naik P, Hanahan D: A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis. Nature 369:414-418, 1994
24. Baserga R: The insulin-like growth factor I receptor: a key to tumor growth? Cancer Res 55:249-252, 1995
25. Bates P, Fisher R, Ward A, et al: Mammary cancer in transgenic mice expressing insulin-like growth factor II (IGF-II). Br J Cancer 72:1189-1193, 1995
26. Buckbinder L, Talbott R, Velasco-Miguel S, et al: Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377:646-649, 1995
27. Zhang L, Kashanchi F, Zhan Q, et al: Regulation of insulin-like growth factor II P3 promotor by p53: a potential mechanism for tumorigenesis. Cancer Res 56:1367-1373, 1996
28. Webster N, Resnik J, Reichart D, et al: Repression of the insulin receptor promoter by the tumor suppressor gene product p53: a possible mechanism for receptor overexpression in breast cancer. Cancer Res 56:2781-2788, 1996
29. Sell C, Baserga R, Rubin R: Insulin-like growth factor I (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis. Cancer Res 55:303-306, 1995
30. Turner B, Haffty B, Narayanan L, et al: Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer re-currence after lumpectomy and radiation. Cancer Res 57:3079-3083, 1997
31. Rasmussen A, Cullen K: Paracrine/autocrine regulation of breast cancer by the insulin-like growth factors. Breast Cancer Res Treat 47:219-233, 1998
32. Giani C, Cullen KJ, Campani D, et al: IGF-II mRNA and protein are expressed in the stroma of invasive breast cancers: an in situ hybridization and immuno-histochemical study. Breast Cancer Res Treat 41:43-50, 1996
33. Cullen KJ, Smith HS, Hill S, et al: Growth factor messenger RNA expression by human breast fibro-blasts from benign and malignant lesions. Cancer Res 51:4978-4985, 1991
34. Singer C, Rasmussen A, Smith H, et al: Malignant breast epithelium selects for IGF-II expression in breast stroma. Evidence for paracrine function. Cancer Res 55:2448-2454, 1995
35. Ellis MJC, Singer C, Hornby A, et al: Insulin-like growth factor mediated stromal-epithelial interactions in human breast cancer. Breast Cancer Res Treat 31:249-261, 1994
36. Huynh H, Alpert L, Pollak M: Pregnancy-dependent growth of mammary tumors is associated with over-expression of insulin-like growth factor II. Cancer Res 56:3651-3654, 1996
37. Manni A, Badger B, Wei L, et al: Hormonal regulation of insulin-like growth factor-II and insulin-like growth factor-binding protein expression by breast cancer cells in vivo. Evidence for stromal epithelial interactions. Cancer Res 54:2934-2942, 1994
38. Torapainen E, Lipponen P, Syrjanen K: Expression of insulin-like growth factor II in female breast cancer as related to established prognostic factors and long term prognosis. Anticancer Res 15:2669-2674, 1995
39. Yu H, Levesque M, Khosravi M, et al: Associations between insulin-like growth factors and their binding proteins and other prognostic indicators in breast cancer. Br J Cancer 74:1242-1247, 1996
40. Foekens JA, Portengen H, van Putten WLJ, et al: Prognostic value of receptors for insulin-like growth factor 1, somatostatin, and epidermal growth factor in human breast cancer. Cancer Res 49:7002-7009, 1989
41. Papa V, Gliozzo B, Clark GM, et al: Insulin-like growth factor receptors are overexpressed and predict a low risk in human breast cancer. Cancer Research 53:3736-3740, 1993
42. Peyrat J, Bonneterre J, Vermin P, et al: Insulin-like growth factor I receptors (IGFI-R) and IGF1 in human breast tumors. J Steroid Biochem Mol Biol 37:823-827, 1990
43. Bonneterre J, Peyrat J, Beuscart R, et al: Prognostic significance of insulin-like growth factor I receptors in human breast cancer. Cancer Res 50:6931-6935, 1990
44. Surmacz E, Guvakova M, Nolan M, et al: Type I insulin-like growth factor receptor function in breast cancer. Breast Cancer Res Treat 47:255-267, 1998
45. Clarke R, Howell A, Anderson E: Type I insulin-like growth factor receptor gene expression in normal human breast tissue treated with oestrogen and progesterone. Br J Cancer 75:251-257, 1997
46. Almeida A, Muleris M, Dutrillaux B, et al: The insulin-like growth factor I receptor gene is the target for the 15q26 amplicon in breast cancer. Genes Chromosomes Cancer 11:63-65, 1994
47. Happerfield L, Miles D, Barnes D, et al: The localization of the insulin-like growth factor receptor I (IGFR1) in benign and malignant breast tissue. Proc AACR Abstract #374, 1997
48. Soos M, Field C, Lammers R, et al: A panel of monoclonal antibodies for the type I insulin-like growth factor receptor. J Biol Chem 267:12955-12963, 1992
49. Ratio M, von Smitten K, Pekonen F: The prognostic value of insulin-like growth factor-I receptor in breast cancer patients. Results of a follow-up study on 126 patients. Eur J Cancer 30A:307-311, 1994
50. Hankins GR, De Souza AT, Bentley RC, et al: M6P/IGF2 receptor: a candidate breast tumor suppressor gene. Oncogene 12:2003-2009, 1996
51. Oates A, Schumaker L, Jenkins S, et al: The mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R), a putative breast tumor suppressor gene. Breast Cancer Res Treat 47:269-281, 1998
52. Claussen M, Buergisser D, Schuller AGP, et al: Regulation of insulin-like growth factor (IGF)-binding protein-6 and mannose 6-phosphate/IGF-II receptor expression in IGF-II-overexpressing NIH 3T3 cells. Mol Endocrinol 9:902-912, 1995
53. Rocha R, Hilsenbeck S, Jackson J, et al: Insulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: correlation with clinical parameters and disease free survival. Clin Cancer Res 3:103-109, 1997
54. Rocha RL, Hilsenbeck SG, Jackson JG, et al: Correlation of insulin-like growth factor-binding protein-3 messenger RNA with protein expression in primary breast cancer tissues: detection of higher levels in tumors with poor prognostic features. J Natl Cancer Inst 88:601-606, 1996
55. Pratt S, Pollak M: Estrogen and antiestrogen modulation of MCF7 human breast cancer cell proliferation is associated with specific alterations in accumulation of insulin-like growth factor-binding proteins in conditioned media. Cancer Res 53:5193-5198, 1993
56. Pratt S, Pollak M: Insulin-like growth factor binding protein 3 (IGF-BP3) inhibits estrogen-stimulated breast cancer cell proliferation. Biochem Biophys Res Commun 198:292-297, 1994
57. Huynh H, Yang X, Pollak M: A role for insulin-like growth factor binding protein 5 in the antiproliferative action of the antiestrogen ICI 182780. Cell Growth Differ 7:1501-1506, 1996
58. Yee D, Jackson J, Kozelsky T, et al: Insulin-like growth factor binding protein 1 expression inhibits insulin-like growth factor I action in MCF-7 breast cancer cells. Cell Growth Differ 5:73-77, 1994
59. Gucev Z, Oh Y, Kelley K, et al: Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor beta2-induced growth inhibition in human breast cancer cells. Cancer Res 56:1545-1550, 1996
60. Lee A, Hilsenbeck S, Yee D: IGF system components as prognostic markers in breast cancer. Breast Cancer Res Treat 47:295-302, 1998
61. Yu H, Levesque M, Clark G, et al: Prognostic value of PSA in breast cancer: A large US cohort study. Proc AACR 38:Abstract #2924, 1997
62. Yu H, Diamandis E, Levesque M, et al: Prostate specific antigen in breast cancer, benign breast disease and normal breast tissue. Breast Cancer Res Treat 40:171-178, 1996